Tom Hemming Karlsen

Shaping the future of European #healthresearch: in this new article, BioMed Alliance presents #policy recommendations for Framework Programme 10 and beyond ➡️ tinyurl.com/yuy563uy @biomedalliance @tomhemmingk @euforea @MrazLab @CarolRemme biomedeurope.org

Impact factors as of 2025 have been released. Proud to be part of the editors team of @EASLnews @JHepatology - standing on the shoulders of efforts by @ProfPaoloAngeli over the past 5 years.

Had an excellent morning lecture from Prof Tom Hemming Karlsen about EASL Lancet Liver Commission, highlighting the importance of primary prevention of liver disease & its implications for public health @EAHPBA @EASLedu @IHPBA @TheLancet @tomhemmingk @Oslounivsykehus @UniOslo

From genetic associations to environmental triggers in PSC. Our EBV-paper is out in @NatureMedicine today. nature.com/articles/s4159…

I didn't have much hope that we'd find genetic determinants of long-COVID, but after years of work, @VilmaAho, @tomoco_naka, @HugoZeberg and @HannaMOllila made it happen! nature.com/articles/s4158…

A special day for PSC. One phase II (in @JHepatology below, elafibranor) and one phase III (nor-UDCA, presented at the #EASLCongress) trial with potentially positive efficacy signals. Great inspiration. journal-of-hepatology.eu/article/S0168-…

Interested in microbiota, mouse models, liver disease and working on an ERC Consolidator grant-funded project? Apply for a postdoc position in my lab! jobbnorge.no/en/available-j…

Interesting combo for our old PSC genetic modifier findings at RSPO3 in @Gut_BMJ gut.bmj.com/content/67/8/1…

⁦Our comprehensive PSC paper online in @DiseasePrimers⁩ today. Thanks to Michael Manns for pulling it through. nature.com/articles/s4157…

It was a pleasure to work with you @tomhemmingk & others on this Comment! By facilitating the transfer of knowledge between medical societies and promoting beneficial regulatory changes, the BioMed Alliance aims to contribute to the European Global Health strategy.

An interesting moment in history to reflect upon global health strategies in Europe and beyond - report from a @Biomedalliance workshop now out in @LancetRH_Europe sciencedirect.com/science/articl…

So what does this mean for the old (and not yet proven) concept of UDCA ‘chemoprevention’ against malignancies in PSC…? science.org/doi/10.1126/sc…

Proud to enter the new year as co-editor of @JHepatology of @EASLnews. CiteScore (counting over 4 years, vs IF only 2) suggests a journal in good shape:

NEW: Today, I’m releasing a Surgeon General’s Advisory on the causal link between alcohol consumption and increased cancer risk. Alcohol is the 3rd leading preventable cause of cancer in the U.S., contributing to about 100,000 cancer cases and 20,000 cancer deaths each year.

📢Our January issue is out❗️ 🎉Celebrating 40 years of discovery in #liverresearch🎉 🙏Thank you to our authors, editors, reviewers, & readers for supporting @JHepatology on this incredible journey #LiverTwitter @EASLnews @EASLedu

After highlighting the steep rise in alcohol-related liver disease in young women, we now highlight an even bigger problem in our children. The highest prevalence of lifetime alcohol use for 11-year-olds (34% girls) was observed in the UK. @Inst_of_Liver doi.org/10.1016/j.jhep…

@EASLnews @TheLancet Commission on Liver Health Interdisciplinary group gathered in Geneva! @ECDC_EU @WHO_Europe @EASOobesity @tomhemmingk 300k premature liver deaths in Europe ! HOW to drive meaningful change- transformational change?

Fantastic to get a new ERC grant! Why is IBD associated with both PSC and steatosis? In the #ERCCoG project #FatVersusBile we will use IBD as a window to the microbial signals from the gut that shape liver health. Exciting days! @ERC_Research @RIIM_UiO_OUS @UniOslo_MED @erc_ncp

Key gap in the European Global Health agenda highlighted by EiC of @LancetRH_Europe @PoojaJha2015 during the @Biomedalliance general assembly in Brussels today: high quality migrant health data.